Gilead Sciences (Australia)
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Gilead Sciences (Australia), Australia, covering academic research published from 2002 to 2023. Read More.
Open Access Percentage
63%
Total
Publications
78
Total Open
Publications
49
Total
Citations
2.8K
Open Access
Percentage
63%
Total
Publications
78
Total Open
Publications
49
Total
Citations
2.8K
Breakdown
Publisher Open
26%
Both
28%
Other Platform Open
9%
Closed
37%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 38%
16
Hybrid 24%
10
No Guarantees 38%
16
Other Platform Open
Domain 86%
25
Institution 21%
6
Public 14%
4
Preprint 7%
2
Other Internet 7%
2
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 25 |
Europe PMC | Domain | 16 |
University of Bristol - Bristol Research | Institution | 4 |
Semantic Scholar | Public | 4 |
University of Groningen / Centre for Information Technology - University of Groningen research database | Institution | 2 |
University of Zurich - Zurich Open Repository and Archive | Institution | 1 |
University of Bern - Bern Open Repository and Information System | Institution | 1 |
University of Adelaide - Adelaide Research & Scholarship (AR&S) | Institution | 1 |
Universitat Autònoma de Barcelona - Dipòsit Digital de Documents de la UAB | Institution | 1 |
unimelb.edu.au OAI-PMH Repository | Institution | 1 |